INTERNATIONAL PATENT: PETRA PHARMA CORPORATION FILES APPLICATION FOR "(R)-3-(6-CHLORO-3-((1-(2-CYCLOPROPYL-6-FLUORO-3-METHYL-4-OXO-4H-CHROMEN-8-YL)ETHYL)AMINO)PYRIDIN-2-YL)-1,2,4-OXADIAZOL-5(4H)-ONE AS PI3K INHIBITOR FOR THE TREATMENT OF CANCER"

GENEVA, Oct. 28 -- PETRA PHARMA CORPORATION (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/025009) for "(R)-3-(6-CHLORO-3-((1-(2-CYCLOPROPYL-6-FLUORO-3-METHYL-4-OXO-4H-CHROMEN-8-YL)ETHYL)AMINO)PYRIDIN-2-YL)-1,2,4-OXADIAZOL-5(4H)-ONE AS PI3K INHIBITOR FOR THE TREATMENT OF CANCER" on Apr 16, 2025. With publication no. WO/2025/221919, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Hua-Yu (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288)

Abstract: The di...